FGEN — Fibrogen Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual income statement for Fibrogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	257	176	235	141	148
Cost of Revenue
Gross Profit	255	167	222	120	129
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	346	368	524	442	430
Operating Profit	-89.3	-192	-289	-301	-282
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-76.6	-189	-291	-295	-287
Provision for Income Taxes
Net Income After Taxes	-77	-189	-291	-295	-287
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	-77	-189	-290	-294	-284
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-77	-189	-290	-294	-284
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.888	-2.11	-3.14	-3.14	-2.84